Systems Serology Core
Systems Serology Core
批准号:
10449292
负责人:
Galit Alter
金额:
$40.74万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-12 至 2026-04-30
关键词:
AddressAdultAffectAntibodiesAntibody ResponseAreaAutologousBenchmarkingBiological AssayBiophysicsBirthCellsCollectionDataDevelopmentEngineeringEnsureEnvironmentFingerprintGenerationsGoalsHumanHuman ResourcesHumoral ImmunitiesImmuneImmune responseImmune systemImmunityImmunologicsInfantInfant HealthInfectionInfrastructureInstitutesInterventionInvestigationKnowledgeLaboratoriesLeadershipLifeMaternal antibodyMaternally-Acquired ImmunityMonitorNatureNeonatalNewborn InfantPregnancyProtocols documentationReagentResearchResourcesRoleRunningSamplingSerologyStandardizationSystemTechnical ExpertiseTechnologyTherapeuticTrainingVaccinationVaccinesWorkantibody testconditioninghigh standardimprovedin uterolaboratory experiencematernal vaccinationneonatal immunityneonatenew technologynext generationnovelprogramsresponsesuccesssynergismtool
中文摘要
核心1 -系统血清学核心-摘要
英文摘要
CORE 1 – SYSTEMS SEROLOGY CORE – ABSTRACT
Accumulating data points to dramatic immunologic changes during pregnancy and early life. However, how these
immune perturbations alter the immune response to vaccination or to infection have yet to be fully defined. Under
Core 1, in depth comprehensive characterization will be performed on the humoral immune response to improve
our understanding of the mechanisms by which the immune system changes throughout pregnancy, how these
changes affect responses to vaccines and how infants benefit from maternal immunity and in turn respond to
vaccines. Specifically, Core 1 will exploit and evolve Systems Serology to broadly and deeply probe the nature
of the humoral immune response in a sample sparing manner, via the development of multiplexed-antibody
profiling approaches. Additionally Core 1 will develop lower-throughput functional assays to probe the interaction
between antibodies and host-innate immune cells, in a fully autologous fashion, to define the overall impact of
altered antibody and cellular state in pregnancy and early life. Thus Core 1 will deeply interrogate and define
changes in humoral immunity throughout pregnancy, at birth, and throughout early infant life. The Core leader
will provide all the expertise, infrastructure, reagents, personnel, and training, to ensure the efficient and
successful analysis and deployment of this technology under Projects 1 & 2, as well as support in generating
data for Projects 2 & 4. Thus the main role of this Core is to provide the leadership and the technical expertise
to ensure that antibody assays are run in a standard fashion, that novel technologies evolve from this Core to
support the needs of the overall Consortium, and that the Consortium is kept abreast of the latest developments
in assessing antibody responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SARS-CoV-2 Variant Testing
-
批准号:10446500
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2021
-
负责人:Galit Alter
-
依托单位:
Systems Serology Core
-
批准号:10616544
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2021
-
负责人:Galit Alter
-
依托单位:
Systems Serology Core
-
批准号:10203487
-
项目类别:
-
资助金额:$39.61万
-
财政年份:2021
-
负责人:Galit Alter
-
依托单位:
Defining humoral correlates of immunity against COVID-19
-
批准号:10265799
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2020
-
负责人:Galit Alter
-
依托单位:
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
-
批准号:10221341
-
项目类别:
-
资助金额:$147.8万
-
财政年份:2020
-
负责人:Galit Alter
-
依托单位:
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children
-
批准号:10159844
-
项目类别:
-
资助金额:$96.06万
-
财政年份:2020
-
负责人:Galit Alter
-
依托单位:
Antibody Optimization Core
-
批准号:10158451
-
项目类别:
-
资助金额:$68.97万
-
财政年份:2019
-
负责人:Galit Alter
-
依托单位:
Antibody Optimization Core
-
批准号:10402341
-
项目类别:
-
资助金额:$69.29万
-
财政年份:2019
-
负责人:Galit Alter
-
依托单位:
Antibody Optimization Core
-
批准号:10617741
-
项目类别:
-
资助金额:$62.43万
-
财政年份:2019
-
负责人:Galit Alter
-
依托单位:
Core B
-
批准号:10339364
-
项目类别:
-
资助金额:$99.39万
-
财政年份:2018
-
负责人:Galit Alter
-
依托单位:
Killing the Reservoir with Antibodies
-
批准号:9197410
-
项目类别:
-
资助金额:$48.61万
-
财政年份:2015
-
负责人:Galit Alter
-
依托单位:
Killing the Reservoir with Antibodies
-
批准号:8656251
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2013
-
负责人:Galit Alter
-
依托单位:
Tuning Fc-effector functions of HIV-specific antibodies
-
批准号:8408897
-
项目类别:
-
资助金额:$60.99万
-
财政年份:2012
-
负责人:Galit Alter
-
依托单位:
Tuning Fc-effector functions of HIV-specific antibodies
-
批准号:8874097
-
项目类别:
-
资助金额:$87.64万
-
财政年份:2012
-
负责人:Galit Alter
-
依托单位:
Tuning Fc-effector functions of HIV-specific antibodies
-
批准号:8691723
-
项目类别:
-
资助金额:$84.27万
-
财政年份:2012
-
负责人:Galit Alter
-
依托单位:
Tuning Fc-effector functions of HIV-specific antibodies
-
批准号:8496714
-
项目类别:
-
资助金额:$67.25万
-
财政年份:2012
-
负责人:Galit Alter
-
依托单位:
The Innate Immune Signals on B Cells that Induce ADCC Antibodies
-
批准号:8332408
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2011
-
负责人:Galit Alter
-
依托单位:
The role of NK cells during acute HCV infection and antiviral therapy
-
批准号:7919782
-
项目类别:
-
资助金额:$17.12万
-
财政年份:2010
-
负责人:Galit Alter
-
依托单位:
Cytolytic antibodies:Bridging the gap between the innate and adaptive immune resp
-
批准号:8072923
-
项目类别:
-
资助金额:$43.39万
-
财政年份:2010
-
负责人:Galit Alter
-
依托单位:
Cytolytic antibodies:Bridging the gap between the innate and adaptive immune resp
-
批准号:7686615
-
项目类别:
-
资助金额:$44.13万
-
财政年份:2009
-
负责人:Galit Alter
-
依托单位:
海外基金